← All stocks

Prime Medicine, Inc.

PRME No buying or selling

CIK 0001894562 #2975 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

9 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Liu David R.

10% owner

—

20,240,945

$66.80M

+0.4%

ARCH Venture Partners XII, LLC entity

10% owner

—

6,230,300

$20.56M

+94.7%

NELSEN ROBERT

Director

—

6,230,300

$20.56M

+94.7%

ARCH Venture Partners X, LLC entity

10% owner

—

6,230,300

$20.56M

+94.7%

GV 2021 GP, L.L.C.

10% owner

—

3,262,440

$10.77M

+85.1%

Gottesdiener Keith Michael

See Remarks

—

682,259

$2.25M

0.0%

Reine Allan

Chief Executive Officer

—

125,000

$412.50K

—

LEE ANN L.

Chief Technical Officer

—

100,000

$330.00K

—

Brudnick Richard

Chief Business Officer

—

20,000

$66.00K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 11

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 21 Oct 2022